May 28, 2025

Statins Recommended for HIV Patients at Risk for Heart Disease

Guidelines from the Department of Health and Human Services recommend statins as primary prevention for people with HIV aged 40 to 75 years who have a 10-year ASCVD risk of 5% or higher.

Conexiant

May 22, 2025

Cardiogenic Shock in Women: Treatment Disparities Persist

New expert consensus statement reveals that women with cardiogenic shock face significant treatment disparities and outlines evidence-based recommendations for improving outcomes.

Conexiant

May 22, 2025

New AAP Guidelines Refresh Atopic Dermatitis Care

Applying topicals 2 to 3 times per week to previously affected areas—even when the skin appears clear—can reduce flare frequency and improve quality of life.

Conexiant

May 14, 2025

USPSTF: Syphilis Screening During Pregnancy Gets A-Rating

USPSTF reaffirms A-rating for universal syphilis screening during pregnancy as congenital syphilis cases reach a 30-year high.

Conexiant

May 07, 2025

Cystic Fibrosis: New Evidence-Based Guidelines for Newborn Screening

New Cystic Fibrosis Foundation guidelines aim to improve consistency, equity, and accuracy in CF newborn screening nationwide.

Conexiant

June 08, 2023

Coalition urges Senate leaders to support REDI Act

A coalition of some 40 organizations representing dentists and physicians, including the ADA, urged the Senate to pass the Resident Education Deferred Interest Act.

ADA News

June 12, 2024

USPSTF Releases Draft Osteoporosis Screening Guidelines

The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.

Conexiant

January 14, 2025

Does Screening Cut Hip Fracture Risks?

"Screening in higher-risk women 65 years or older was associated with a small absolute risk reduction in hip and major fractures compared with usual care."

Conexiant

January 18, 2023

The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials

Learn about the emerging and effective CAR T-cell therapy, its role in treating refractory lymphoma and myeloma, and the important role of advanced practice providers (APPs) as study coordinators. This comprehensive content covers FDA approvals, the treatment landscape, production to cell infusion process, and common toxicities.

JADPRO